The ESMO Gastrointestinal Cancers Congress is a leading international meeting dedicated to advancing the research, prevention, diagnosis, and treatment of gastrointestinal (GI) cancers. Each year, it brings together world‑renowned specialists, clinical researchers, and healthcare professionals who are shaping the future of GI oncology.

In 2026, the ESMO Gastrointestinal Cancers Congress will take place from 1 to 4 July in Munich, Germany, and will also be accessible online through a dedicated virtual platform.

Organiser
European Society for Medical Oncology (ESMO)

Designed to foster scientific exchange and multidisciplinary collaboration, the congress will feature an engaging programme that includes expert‑led sessions, tumour boards, debates on clinical controversies, and presentations of cutting‑edge research. Participants will have the opportunity to explore new evidence, discuss emerging treatment strategies, and gain insights into the rapidly evolving landscape of GI cancer care.

The scientific content will span the full continuum of patient management—from early detection and biomarker‑driven decision‑making to innovations in systemic therapy and improvements in patient quality of life.

What to Expect:

• Expert discussions led by global leaders in GI oncology
• Multidisciplinary tumour boards and case‑based sessions
• Practical insights for applying new evidence in clinical practice
• Debates on the latest scientific and clinical developments
• Opportunities to connect, collaborate, and share perspectives with peers

Join this influential congress to contribute to meaningful progress, shape clinical practice, and help improve outcomes for patients with gastrointestinal cancers worldwide.